Akhtari M, Bragin A, Cohen M (2008) Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy. Epilepsia 49(8):1419–1430

PubMed  PubMed Central  Google Scholar 

Albers CE, Hofstetter W, Siebenrock KA et al (2013) In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7(1):30–36

CAS  PubMed  Google Scholar 

Alnaqbi N, Mohammad MG, Hamoudi R et al (2023) Molecular heterogeneity of the brain endothelium. Curr Issues Mol Biol 45(4):3462–3478

CAS  PubMed  PubMed Central  Google Scholar 

Awashra M, Mlynarz P (2023) The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective. Nanoscale Adv 5(10):2674–2723

CAS  PubMed  PubMed Central  Google Scholar 

Bakchine S (2019) Commentary: treating Alzheimer's disease: combine or fail?[J]. J Prev Alzheimer’s Dis 6(3):174–176

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397(10291):2284–2303

CAS  PubMed  Google Scholar 

Buhlman LM (2017) Parkin loss-of-function pathology: premature neuronal senescence induced by high levels of reactive oxygen species? Mech Ageing Dev 161(Pt A):112–120

CAS  PubMed  Google Scholar 

Cesarman-Maus G, Hajjar KA (2005) Molecular mechanisms of fibrinolysis. Br J Haematol 129(3):307–321

CAS  PubMed  Google Scholar 

Colasuonno M, Palange AL, Aid R et al (2018) Erythrocyte-inspired discoidal polymeric nanoconstructs carrying tissue plasminogen activator for the enhanced lysis of blood clots. ACS Nano 12(12):12224–12237

CAS  PubMed  Google Scholar 

Cutinho VA, Mourya LI (2020) Approaches for encephalic drug delivery using nanomaterials: the current status[J]. Brain Res Bull 155:184–190

PubMed  Google Scholar 

de Ruiter GC, Onyeneho IA, Liang ET et al (2008) Methods for in vitro characterization of multichannel nerve tubes[J]. J Biomed Mater Res A 84(3):643–651

PubMed  Google Scholar 

Dong X (2018) Current strategies for brain drug delivery. Theranostics 8(6):1481–1493

CAS  PubMed  PubMed Central  Google Scholar 

Edrey YH, Oddo S, Cornelius C et al (2014) Oxidative damage and amyloid-beta metabolism in brain regions of the longest-lived rodents[J]. J Neurosci Res 92(2):195–205

CAS  PubMed  Google Scholar 

Esiri MM (2007) Ageing and the brain. J Pathol 211(2):181–187

CAS  PubMed  Google Scholar 

Fang X, Border JJ, Zhang H et al (2025) A soluble epoxide hydrolase inhibitor improves cerebrovascular dysfunction, neuroinflammation, amyloid burden, and cognitive impairments in the hAPP/PS1 TgF344-AD rat model of Alzheimer’s disease[J]. Int J Mol Sci 26(6):2433

Gambaryan PY, Kondrasheva IG, Severin ES et al (2014) Increasing the efficiency of Parkinson’s disease treatment using a poly(lactic-co-glycolic acid) (PLGA) based L-DOPA delivery system. Exp Neurobiol 23(3):246–252

CAS  PubMed  PubMed Central  Google Scholar 

Gao N, Dong K, Zhao A et al (2016) Polyoxometalate-based nanozyme: design of a multifunctional enzyme for multi-faceted treatment of Alzheimer’s disease. Nano Res 9(4):1079–1090

CAS  Google Scholar 

Grebinyk A, Prylutska S, Grebinyk S et al (2022) Drug delivery with a pH-sensitive star-like dextran-graft polyacrylamide copolymer. Nanoscale Adv 4(23):5077–5088

CAS  PubMed  PubMed Central  Google Scholar 

Guler E, Kopuz A, Ertas B et al (2024) Anti-Alzheimer’s effect of memantine/donepezil/metformin-loaded PVA/PEO composite nanofibers produced by pressurized gyration: production, characterization, and in vitro evaluation. J Drug Deliv Sci Technol 97:105795

CAS  Google Scholar 

He X, Yang L, Wang Z et al (2021) Solid lipid nanoparticles loading with Curcumin and dexanabinol to treat major depressive disorder. Neural Regen Res 16(3):537–542

CAS  PubMed  Google Scholar 

He Y, Wang Y, Wang L et al (2024) Understanding nanoparticle-liver interactions in nanomedicine[J]. Expert Opin Drug Deliv 21(6):829–843

CAS  PubMed  PubMed Central  Google Scholar 

Huang R, Ma H, Guo Y et al (2013) Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson’s disease. Pharm Res 30(10):2549–2559

CAS  PubMed  Google Scholar 

Huang L, Zhang X, Ding Z et al (2022) PEGylated 2D-nanomaterials alleviate parkinson’s disease by shielding PIP2 lipids to inhibit IP3 second messenger signaling. Nano Today 46:101556

CAS  Google Scholar 

Hussain G, Wang J, Rasul A et al (2019) Role of cholesterol and sphingolipids in brain development and neurological diseases. Lipids Health Dis 18(1):26

PubMed  PubMed Central  Google Scholar 

Jia J, Li C, Zhang T et al (2019) CeO(2)@PAA-LXW7 attenuates LPS-Induced inflammation in BV2 Microglia[J]. Cell Mol Neurobiol 39(8):1125–1137

CAS  PubMed  PubMed Central  Google Scholar 

Juenet M, Aid-Launais R, Li B et al (2018) Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin. Biomaterials 156:204–216

CAS  PubMed  Google Scholar 

Kasai T, Umeda Y, Ohnishi M et al (2015) Thirteen-week study of toxicity of fiber-like multi-walled carbon nanotubes with whole-body inhalation exposure in rats. Nanotoxicology 9(4):413–422

CAS  PubMed  Google Scholar 

Kataria S, Roy S, Chaurasia M et al (2023) Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model. Drug Dev Ind Pharm 49(8):521–535

CAS  PubMed  Google Scholar 

Kong L, Li X, Ni Y et al (2020) Transferrin-Modified osthole pegylated liposomes travel the Blood-Brain barrier and mitigate alzheimer’s Disease-Related pathology in APP/PS-1 Mice[J]. Int J Nanomed 15:2841–2858

CAS  Google Scholar 

Kwon HJ, Kim D, Seo K et al (2018) Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in parkinson’s Disease[J]. Angew Chem Int Ed Engl 57(30):9408–9412

CAS  PubMed  Google Scholar 

Lee B, Lee K, Panda S et al (2018) Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat Biomed Eng 2(7):497–507

CAS  PubMed  PubMed Central  Google Scholar 

Lei L, Tu Q, Jiao L et al (2022) Reactive oxygen species scavenging by hemin-based nanosheets reduces parkinson’s disease symptoms in an animal model[J]. Chem Eng J 432:134356

CAS  Google Scholar 

LeWitt PA, Hauser RA, Pahwa R et al (2019) Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with parkinson’s disease: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Neurol 18(2):145–154

CAS  PubMed  Google Scholar 

Li S, Wang Y, Wu M et al (2022) Spleen-Targeted Glabridin-Loaded nanoparticles regulate polarization of monocyte/macrophage (M(o) /M(phi)) for the treatment of cerebral Ischemia-Reperfusion Injury[J]. Adv Mater 34(39):e2204976

PubMed  PubMed Central  Google Scholar 

Li S, Chen Z, Wang M et al (2024) Ultrasmall Cu(2)O@His nanozymes with RONS scavenging capability for anti-inflammatory therapy. ACS Appl Mater Interfaces 16(3):3116–3125

CAS  PubMed  Google Scholar 

Lin Z, Monteiro-Riviere NA, Riviere JE (2015) Pharmacokinetics of metallic nanoparticles[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7(2):189–217

CAS  PubMed  Google Scholar 

Liu H, Hua M, Chen P et al (2010) Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255(2):415–425

PubMed  Google Scholar 

Liu X, An C, Jin P et al (2013) Protective effects of cationic bovine serum albumin-conjugated pegylated Tanshinone IIA nanoparticles on cerebral ischemia. Biomaterials 34(3):817–830

CAS  PubMed  Google Scholar 

Liu J, Chang L, Song Y et al (2019) The role of NMDA receptors in Alzheimer’s disease. Front Neurosci 8:13:43. https://doi.org/10.3389/fnins.2019.00043

PubMed  PubMed Central  Google Scholar 

Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312–339

CAS  PubMed  PubMed Central  Google Scholar 

Ma C, Hong F, Yang S (2022) Amyloidosis in Alzheimer’s disease: pathogeny, etiology, and related therapeutic directions. Molecules 27(4):1210.